Article
LRRK2 in Infection: Friend or Foe?
27 Mar 2019
Abstract excerpt
In the field of Parkinson's disease (PD) research, leucine-rich repeat kinase 2 (LRRK2) remains one of the most enigmatic kinases. LRRK2 pathogenic mutations result in increased kinase activity, making LRRK2 an attractive therapeutic target for PD. For over 10 years, the identification of a bona fide substrate and a physiological function for LRRK2 has been elusive, and only recently, Rab GTPases were identified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
